CBUS
Cibus, Inc.NASDAQHealthcare$1.98-3.54%ClosedMarket Cap: $90.1M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
40.04
P/S
23.88
EV/EBITDA
-5.60
DCF Value
$-0.65
FCF Yield
-58.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.9%
Operating Margin
-2429.6%
Net Margin
-3492.3%
ROE
-236.8%
ROA
-41.7%
ROIC
-30.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.1M | -30.1% | $-13.5M | $-31.3M | $-0.39 | — |
| FY 2025 | $3.6M | -62.8% | $-67.5M | $-127.1M | $-2.78 | — |
| Q3 2025 | $615.0K | -126.7% | $-15.4M | $-23.5M | $-0.44 | — |
| Q2 2025 | $933.0K | 100.0% | $-17.9M | $-25.4M | $-0.61 | — |
| Q1 2025 | $1.0M | 100.0% | $-41.6M | $-46.9M | $-2.02 | — |
| Q4 2024 | $1.2M | 100.0% | $-18.0M | $-23.1M | $-0.87 | — |
| FY 2024 | $4.3M | 100.0% | $-258.4M | $-251.4M | $-10.83 | — |
| Q3 2024 | $1.7M | 100.0% | $-200.4M | $-180.0M | $-7.63 | — |
| Q2 2024 | $838.0K | -106.8% | $-21.5M | $-24.9M | $-1.14 | — |
| Q1 2024 | $545.0K | -224.2% | $-18.5M | $-23.4M | $-1.12 | — |
| Q4 2023 | $1.1M | -64.8% | $-19.9M | $-217.1M | $-12.02 | — |
| FY 2023 | $1.8M | 78.3% | $-318.9M | $-267.6M | $-25.95 | — |